A Nature Chemical Biology study reported a discovery strategy for charged molecular glues enabled by targeted degron display. The work describes a method to identify small molecules that promote specific protein-protein interactions that can be exploited for degradation or functional inhibition. The approach is aimed at expanding the toolbox for targeted therapeutics, particularly in targeted protein degradation where “molecular glue” mechanisms can circumvent traditional active-site constraints. While the coverage is positioned as discovery-focused, the platform concept is directly relevant to pipeline teams building next-generation degrader programs. For biotech, the item adds to the accelerating push toward systematic, engineering-led ways to find actionable glue-like chemistries rather than relying on purely screening-based serendipity.